Legal Representation
Attorney
Timothy D. Pecsenye
USPTO Deadlines
Next Deadline
1168 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-10-04)
Due Date
October 04, 2028
Grace Period Ends
April 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 4, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 30, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 29, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 29, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 27, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 21, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 2, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 2, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 31, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 5, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 5, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 25, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 25, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 11, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of pain associated with inflammation, chronic inflammatory disease of musculoskeletal system, post-traumatic inflammation of soft tissue and musculoskeletal system, pain in the spine, neuralgia, myalgia, arthralgia, pain and inflammation after surgery or injury, pain in gout, and migraine
First Use Anywhere:
Oct 25, 2021
First Use in Commerce:
Oct 25, 2021
Classification
International Classes
005